From: Quality of care in type 2 diabetes in Iran; a cross-sectional study using patient-level data
Index | 2013 | 2014 | 2015 | 2016 | 2017 |
---|---|---|---|---|---|
Glycemic control monitoring | |||||
Percentage of HbA1c test ≥ 1 per three months (Number) | 8 (158) | 9 (178) | 10 (198) | 10 (198) | 9 (178) |
Percentage of patients without HbA1c test annually (Number) | 13 (257) | 10 (198) | 7 (138) | 6 (119) | 2 (40) |
Mean HbA1c test per year per patient | 1.62 | 1.71 | 1.82 | 1.86 | 1.89 |
Lipid profile monitoring | |||||
Mean Serum lipid test ≥ 1 per year | 1.50 | 1.65 | 1.63 | 1.68 | 1.59 |
Percentage of patients without LDL test (number) | 13 (258) | 8 (159) | 8 (159) | 7 (139) | 7 (139) |
Nephropathy screening | |||||
Percentage of urine protein test ≥ 1 per year (number) | 46(913) | 45(893) | 43(854) | 47(933) | 42(834) |
Mean Urine protein test per year per patient | 0.55 | 0.54 | 0.55 | 0.61 | 0.53 |
ABC care | |||||
Percentage of ABC care1 (Number) | 0.008 [15] | 0.015 [20] | 0.017 [21] | 0.018 [22] | 0.017 [23] |
Percentage of ABC care2 (Number) | 0.28 (547) | 0.28 (549) | 0.30 (588) | 0.33 (652) | 0.29 (565) |